{"id":1016632,"date":"2026-11-03T07:32:45","date_gmt":"2026-11-03T12:32:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/"},"modified":"2026-11-03T07:32:45","modified_gmt":"2026-11-03T12:32:45","slug":"foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/","title":{"rendered":"Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WATERTOWN, Mass., Nov.  03, 2026  (GLOBE NEWSWIRE) &#8212; Foghorn<sup>\u00ae<\/sup> Therapeutics Inc. (Nasdaq: FHTX), a biotechnology company pioneering a new class of medicines against challenging targets in oncology and immunology &amp; inflammation, today announced that management will participate in the Guggenheim Third Annual Healthcare Innovation Conference, Stifel 2026 Healthcare Conference, and Jefferies 2026 London Healthcare Conference.<\/p>\n<p>\n        <strong>Guggenheim Third Annual Healthcare Innovation Conference<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Fireside Chat: Tuesday, November 10, 2026, at 3:30 p.m. ET<\/li>\n<li>Presenter: Adrian Gottschalk, President and Chief Executive Officer<\/li>\n<li>Registration link: <a href=\"https:\/\/event.summitcast.com\/view\/oVDtKqmPn2tPc7VV7WsLAC\/6RA3dXUVunzfFa6Zu4pdcc\" rel=\"nofollow\" target=\"_blank\">Register here<\/a><\/li>\n<li>Management will also participate in one-on-one meetings\n<\/li>\n<\/ul>\n<p>\n        <strong>Stifel 2026 Healthcare Conference<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Presentation: Wednesday, November 11, 2026, at 10:00 a.m. ET<\/li>\n<li>Presenter: Adrian Gottschalk, President and Chief Executive Officer<\/li>\n<li>Management will also participate in one-on-one meetings\n<\/li>\n<\/ul>\n<p>\n        <strong>Jefferies 2026 London Healthcare Conference<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Fireside Chat: Monday, November 16, 2026, at 4:30 p.m. GMT<\/li>\n<li>Presenter: Adrian Gottschalk, President and Chief Executive Officer<\/li>\n<li>Management will also participate in one-on-one meetings\n<\/li>\n<\/ul>\n<p>A webcast of the Guggenheim fireside chat can be accessed under \u201cEvents &amp; Presentations\u201d in the Investors section of the Company\u2019s website <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Fw09CCx4VRQPbZ60KPcALYLCMfde1hJMLQg9vj_GAQWzc0o-BjmfaSEnKj4JPZ9792FMYPjQb0-eEHdYTpW0hyYXhK0cFCIz_n-z023qmxMpQsTxRjl0RBEV9uYeqe7C\" rel=\"nofollow\" target=\"_blank\">here<\/a> and will be available for 90 days.<\/p>\n<p align=\"justify\">\n        <strong>About Foghorn Therapeutics<\/strong><br \/>\n        <br \/>Foghorn<sup>\u00ae<\/sup> Therapeutics is a biotechnology company developing novel medicines against challenging biological targets through multiple modalities and approaches, including oral small molecules, targeted protein degradation and induced proximity. The Company is advancing programs in oncology as well as immunology &amp; inflammation. Foghorn brings together deep biological understanding and small-molecule drug discovery expertise to pursue challenging targets with selectivity. Visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Eix0zDTIliHg9jLf0U5q2mM5Hb8s-qyWY6DrY4sp5tzM42n6f0dtFqq4hU-P9jlgTukUVLxAulqugysEWI5nLrHqtnC-ipFyIzRso-SmRT4=\" rel=\"nofollow\" target=\"_blank\">www.foghorntx.com<\/a> for more information on the Company, and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QKPbAkoHId5KHLvqFec7zkOs-Cmpys0c5dXEm9FHcmnyPr-hDFkcMokdpcYgGktfLn_sXCLI5P-HDD0aPotcPQ==\" rel=\"nofollow\" target=\"_blank\">X<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cnBSESabDhbcaJYznsWIjGdWSrOQklpfXffeN4sEzsf1Iyl3OI0iAi5TAbPBtvCpd99aMVj3muT3qEW0PnhWcdgCdo20Dz0c1ez7YlW9m4s4mFo8Nd20yBu0l5jGsleC\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Karin Hellsvik, Foghorn Therapeutics Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ixdwvxNzUFzjM424Dx8-cnVbn1DzLjrCMFxS2V2T4Xm7PZ6yWhM9c-G-b7vsmfAS2C6DPFRlnGaFceCzciHgaxIxc3zneBNj5niQkMl5Pu4=\" rel=\"nofollow\" target=\"_blank\">khellsvik@foghorntx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODgwNSM3OTQxMzEwIzIyMDI4NjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmI3NmZhZDgtMWM3Ni00NWY4LWIzYzctYjNlOTYwYjhiNTVlLTEyMTQ0MTUtMjAyNi0xMS0wMy1lbg==\/tiny\/Foghorn-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) &#8212; Foghorn\u00ae Therapeutics Inc. (Nasdaq: FHTX), a biotechnology company pioneering a new class of medicines against challenging targets in oncology and immunology &amp; inflammation, today announced that management will participate in the Guggenheim Third Annual Healthcare Innovation Conference, Stifel 2026 Healthcare Conference, and Jefferies 2026 London Healthcare Conference. Guggenheim Third Annual Healthcare Innovation Conference Fireside Chat: Tuesday, November 10, 2026, at 3:30 p.m. ET Presenter: Adrian Gottschalk, President and Chief Executive Officer Registration link: Register here Management will also participate in one-on-one meetings Stifel 2026 Healthcare Conference Presentation: Wednesday, November 11, 2026, at 10:00 a.m. ET Presenter: Adrian Gottschalk, President and Chief Executive Officer Management will also participate in one-on-one meetings Jefferies 2026 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1016632","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) &#8212; Foghorn\u00ae Therapeutics Inc. (Nasdaq: FHTX), a biotechnology company pioneering a new class of medicines against challenging targets in oncology and immunology &amp; inflammation, today announced that management will participate in the Guggenheim Third Annual Healthcare Innovation Conference, Stifel 2026 Healthcare Conference, and Jefferies 2026 London Healthcare Conference. Guggenheim Third Annual Healthcare Innovation Conference Fireside Chat: Tuesday, November 10, 2026, at 3:30 p.m. ET Presenter: Adrian Gottschalk, President and Chief Executive Officer Registration link: Register here Management will also participate in one-on-one meetings Stifel 2026 Healthcare Conference Presentation: Wednesday, November 11, 2026, at 10:00 a.m. ET Presenter: Adrian Gottschalk, President and Chief Executive Officer Management will also participate in one-on-one meetings Jefferies 2026 &hellip; Continue reading &quot;Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-03T12:32:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODgwNSM3OTQxMzEwIzIyMDI4NjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November\",\"datePublished\":\"2026-11-03T12:32:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/\"},\"wordCount\":267,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODgwNSM3OTQxMzEwIzIyMDI4NjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/\",\"name\":\"Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODgwNSM3OTQxMzEwIzIyMDI4NjI=\",\"datePublished\":\"2026-11-03T12:32:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODgwNSM3OTQxMzEwIzIyMDI4NjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2ODgwNSM3OTQxMzEwIzIyMDI4NjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/","og_locale":"en_US","og_type":"article","og_title":"Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November - Market Newsdesk","og_description":"WATERTOWN, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) &#8212; Foghorn\u00ae Therapeutics Inc. (Nasdaq: FHTX), a biotechnology company pioneering a new class of medicines against challenging targets in oncology and immunology &amp; inflammation, today announced that management will participate in the Guggenheim Third Annual Healthcare Innovation Conference, Stifel 2026 Healthcare Conference, and Jefferies 2026 London Healthcare Conference. Guggenheim Third Annual Healthcare Innovation Conference Fireside Chat: Tuesday, November 10, 2026, at 3:30 p.m. ET Presenter: Adrian Gottschalk, President and Chief Executive Officer Registration link: Register here Management will also participate in one-on-one meetings Stifel 2026 Healthcare Conference Presentation: Wednesday, November 11, 2026, at 10:00 a.m. ET Presenter: Adrian Gottschalk, President and Chief Executive Officer Management will also participate in one-on-one meetings Jefferies 2026 &hellip; Continue reading \"Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-03T12:32:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODgwNSM3OTQxMzEwIzIyMDI4NjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November","datePublished":"2026-11-03T12:32:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/"},"wordCount":267,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODgwNSM3OTQxMzEwIzIyMDI4NjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/","name":"Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODgwNSM3OTQxMzEwIzIyMDI4NjI=","datePublished":"2026-11-03T12:32:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODgwNSM3OTQxMzEwIzIyMDI4NjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2ODgwNSM3OTQxMzEwIzIyMDI4NjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-november\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016632"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016632\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1016632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1016632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}